These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15789920)

  • 21. Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal.
    Orunesu E; Bagnasco M; Salmaso C; Altrinetti V; Bernasconi D; Del Monte P; Pesce G; Marugo M; Mela GS
    Eur J Clin Invest; 2004 Mar; 34(3):210-7. PubMed ID: 15025680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
    N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of Graves' thyrotoxicosis after antithyroid drug treatment.
    Chiou SC; Houng HS; Li KL; Ghang TC; Lo SK; Sun RH; Huang YY; Hsu BR; Lin JD; Hunang BY
    Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):305-14. PubMed ID: 8851978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of relapse of Graves' disease by treatment with an intrathyroid injection of dexamethasone.
    Mao XM; Li HQ; Li Q; Li DM; Xie XJ; Yin GP; Zhang P; Xu XH; Wu JD; Chen SW; Wang SK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4984-91. PubMed ID: 19850691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
    Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
    Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease.
    Tagami T; Yambe Y; Tanaka T; Tanaka T; Ogo A; Yoshizumi H; Kaise K; Higashi K; Tanabe M; Shimazu S; Usui T; Shimatsu A; Naruse M;
    Intern Med; 2012; 51(17):2285-90. PubMed ID: 22975536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Immunosuppressive Therapy Improve Outcomes in Graves' Disease? A Systematic Review and Meta-Analysis.
    Struja T; Guebelin L; Kutz A; Fehlberg H; Mueller B; Schuetz P
    Thyroid; 2016 May; 26(5):634-40. PubMed ID: 26953215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
    Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessment of antithyroid drug therapy of Graves' disease.
    Feldt-Rasmussen U; Glinoer D; Orgiazzi J
    Annu Rev Med; 1993; 44():323-34. PubMed ID: 7682804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease.
    Bouma DJ; Kammer H; Greer MA
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1138-42. PubMed ID: 6182155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated presentation of Graves' disease as a manifestation of immune reconstitution syndrome in an HIV-infected patient taking HAART: case report.
    Visković K; Stemberger L; Brnić Z; Begovac J
    Acta Clin Croat; 2013 Mar; 52(1):125-7. PubMed ID: 23837283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse following antithyroid drug therapy for Graves' hyperthyroidism.
    Laurberg P; Krejbjerg A; Andersen SL
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):415-21. PubMed ID: 25111942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble intercellular adhesion molecule-1 and Graves' disease.
    Escobar-Morreale HF; Serrano J; Sancho JM; Varela C
    Thyroid; 1997 Oct; 7(5):801-3. PubMed ID: 9349588
    [No Abstract]   [Full Text] [Related]  

  • 34. Th17 and Treg cells in adolescents with Graves' disease. Impact of treatment with methimazole on these cell subsets.
    Klatka M; Grywalska E; Partyka M; Charytanowicz M; Kiszczak-Bochynska E; Rolinski J
    Autoimmunity; 2014 May; 47(3):201-11. PubMed ID: 24443787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease.
    Rojano J; Sasián S; Gavilán I; Aguilar M; Escobar L; Girón JA
    Eur J Endocrinol; 1998 Sep; 139(3):314-6. PubMed ID: 9758442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves' disease compared with adolescent patients.
    Sato H; Minamitani K; Minagawa M; Kazukawa I; Sugihara S; Wataki K; Konda S; Inomata H; Sanayama K; Kohno Y; Sasaki N
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):677-83. PubMed ID: 24756042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.
    Uchida T; Goto H; Kasai T; Komiya K; Takeno K; Abe H; Shigihara N; Sato J; Honda A; Mita T; Kanazawa A; Fujitani Y; Watada H
    Endocrine; 2014 Nov; 47(2):506-11. PubMed ID: 24493028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid preoperative preparation for severe hyperthyroid Graves' disease.
    Panzer C; Beazley R; Braverman L
    J Clin Endocrinol Metab; 2004 May; 89(5):2142-4. PubMed ID: 15126532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited cutaneous systemic sclerosis arising in a patient with Graves' disease.
    Yu MG; Quisumbing JP
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28130289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Graves' disease].
    Illouz F; Rodien P
    Rev Prat; 2014 Jun; 64(6):828-34. PubMed ID: 25090772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.